Paroxetine (Paxil) and congenital malformations
- 22 November 2005
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 173 (11) , 1320-1321
- https://doi.org/10.1503/cmaj.051421
Abstract
Reason for posting: Selective serotonin reuptake inhibitors (SSRIs) have not previously been demonstrated, as a group, to be teratogenic.[1][1] However, the results of an unpublished study[2][2] by GlaxoSmithKline (GSK) has led the US Food and Drug Administration and Health Canada to warn that oneKeywords
This publication has 2 references indexed in Scilit:
- Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studiesPharmacoepidemiology and Drug Safety, 2005
- The Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Breast-feedingJournal of Clinical Psychopharmacology, 2005